TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetesConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statementsConsensus statements

Diabetes mellitus (DM) and hepatitis C virus (HCV) infection are prevalent diseases globally and emerging evidence demonstrates the bidirectional association between the two diseases. Direct-acting antivirals (DAAs) for HCV have a high treatment success rate and can significantly reduce the risks of...

Full description

Bibliographic Details
Main Authors:	Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Journal of the Formosan Medical Association
Subjects:	Consensus statement Direct-acting antivirals Diabetes mellitus Hepatitis C virus
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664623000335

Internet

http://www.sciencedirect.com/science/article/pii/S0929664623000335

Internet

Similar Items